 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
AMARIN CORP PLC A, (AMRN) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Amarin Corporation plc, a neuroscience pharmaceutical company, engages in the development and commercialization of novel drugs for the treatment of neurological disorders affecting the central nervous system. The companys principal compound, Miraxion, is in phase III development for Huntington's disease. It also develops Miraxion for the treatment of other central nervous system disorders, including treatment unresponsive depression. The company, formerly known as Ethical Holdings plc, was incorporated in 1989 and is headquartered in London.
|
|
|
|
|
